
Why are young people still dying from meningitis?
This Is Why
00:00
Why MenB isn't routine for teens
Thomas Moore discusses vaccine development cost, JCVI cost-effectiveness decisions, and policy trade-offs.
Play episode from 12:57
Transcript

Thomas Moore discusses vaccine development cost, JCVI cost-effectiveness decisions, and policy trade-offs.